- Home
- IXHL vs EVOK Comparison
IXHL vs EVOK Comparison
Compare IXHL & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- EVOK
- Stock Information
- Founded
- IXHL 2001
- EVOK 2007
- Country
- IXHL Australia
- EVOK United States
- Employees
- IXHL N/A
- EVOK N/A
- Industry
- IXHL
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- IXHL
- EVOK Health Care
- Exchange
- IXHL Nasdaq
- EVOK Nasdaq
- Market Cap
- IXHL 3.6M
- EVOK 4.2M
- IPO Year
- IXHL N/A
- EVOK 2013
- Fundamental
- Price
- IXHL $0.18
- EVOK $2.95
- Analyst Decision
- IXHL
- EVOK
- Analyst Count
- IXHL 0
- EVOK 0
- Target Price
- IXHL N/A
- EVOK N/A
- AVG Volume (30 Days)
- IXHL 146.9M
- EVOK 14.3K
- Earning Date
- IXHL 05-15-2025
- EVOK 05-13-2025
- Dividend Yield
- IXHL N/A
- EVOK N/A
- EPS Growth
- IXHL N/A
- EVOK N/A
- EPS
- IXHL N/A
- EVOK N/A
- Revenue
- IXHL $98,000.00
- EVOK $11,594,083.00
- Revenue This Year
- IXHL $3,817.06
- EVOK $57.82
- Revenue Next Year
- IXHL $66.67
- EVOK $59.12
- P/E Ratio
- IXHL N/A
- EVOK N/A
- Revenue Growth
- IXHL N/A
- EVOK 89.89
- 52 Week Low
- IXHL $0.08
- EVOK $1.94
- 52 Week High
- IXHL $3.55
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- IXHL 42.72
- EVOK 38.86
- Support Level
- IXHL $0.18
- EVOK $3.33
- Resistance Level
- IXHL $0.21
- EVOK $3.66
- Average True Range (ATR)
- IXHL 0.03
- EVOK 0.29
- MACD
- IXHL 0.01
- EVOK -0.06
- Stochastic Oscillator
- IXHL 6.64
- EVOK 2.99
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.